• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

HAL Lenses Outperform DIMS in Chinese Children’s Myopia Control

by
November 7, 2026
in Health
Reading Time: 5 mins read
0
HAL Lenses Outperform DIMS in Chinese Children's Myopia Control

HAL Lenses Outperform DIMS in Chinese Children's Myopia Control

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a large real-world retrospective cohort study published in Eye and Vision, researchers compared the effectiveness of four distinct myopia control interventions in Chinese children. The study, conducted at C-MER (Shenzhen) Dennis Lam Eye Hospital, evaluated defocus incorporated multiple segments (DIMS) spectacle lenses, highly aspherical lenslet (HAL) spectacle lenses, and their respective combinations with low-concentration atropine (0.01%). The primary finding was that HAL monotherapy was associated with significantly slower myopia progression compared to DIMS, while the combination of HAL lenses with atropine (HALA) demonstrated the highest likelihood of achieving a clinically favorable treatment response.

Myopia has emerged as a global public health concern, necessitating effective strategies to slow its progression and prevent vision-threatening complications in children. Optical interventions based on defocus modification technology have shown significant efficacy in this regard. While both DIMS and HAL lenses have individually demonstrated the ability to slow axial elongation and refractive progression compared to single-vision lenses, direct comparisons between these two optical platforms have yielded variable results in previous literature. Some studies reported equivalent performance, while others suggested that HAL might provide better control of axial elongation, particularly in Chinese populations.

The study included 347 children aged 6 to 14 years, encompassing a total of 694 eyes. Participants were required to have continuously received one of the four interventions for at least one year. The four groups were defined by their treatment strategy: the DIMS group, the HAL group, the DIMSA group (DIMS plus 0.01% atropine), and the HALA group (HAL plus 0.01% atropine).

Researchers utilized linear mixed models and generalized estimating equations to analyze the data, adjusting for covariates such as age, sex, follow-up interval, and baseline ocular parameters. This statistical approach allowed the team to account for the hierarchical structure of the data, where two eyes are nested within each participant, and to control for baseline imbalances between the treatment groups. The analysis focused on the first year of treatment, providing a snapshot of the interventions’ effectiveness during the initial phase of myopia management.

The results indicated that annual axial elongation differed significantly among the four groups. After adjustment, the marginal means for annual axial elongation were 0.23 mm for the DIMS group, 0.15 mm for the HAL group, 0.20 mm for the DIMSA group, and 0.12 mm for the HALA group. Post hoc comparisons revealed that both HAL and HALA were superior to DIMS in slowing axial elongation. Furthermore, HALA was significantly more effective than DIMSA. However, adding 0.01% atropine to either optical monotherapy did not provide a significant additional benefit in terms of mean axial length outcomes when comparing DIMS to DIMSA or HAL to HALA directly.

Similar patterns were observed in the progression of spherical equivalent refraction. The HAL and HALA groups demonstrated significantly less SER progression than the DIMS group. The HALA group also showed superior outcomes compared to the DIMSA group. Once again, the addition of atropine did not yield a statistically significant improvement in mean SER outcomes when added to the respective optical monotherapies. These findings suggest that while the combination therapies may offer advantages in specific response categories, the average refractive benefit of adding low-concentration atropine to these specific optical designs was not significant in this cohort.

A key aspect of the study was the categorization of treatment response into good, fair, or poor based on predefined clinical thresholds. For axial length, a good response was defined as an annual elongation of 0.20 mm or less. The proportion of eyes achieving a good response was highest in the HALA group at 71.6%, followed closely by the HAL group at 71.3%. In contrast, the DIMS group had the lowest proportion of good responders at 44.7%. Compared with DIMS, HALA was associated with the highest odds of a good response for axial length, with an odds ratio of 4.34. This indicates that children using HALA lenses were significantly more likely to achieve a favorable axial length outcome than those using DIMS lenses.

When evaluating treatment response based on SER progression, the HALA group again showed the highest proportion of good responders at 89.7%. The HAL group followed with 77.7%, while the DIMS group had 65.2%. The generalized estimating equation model confirmed that HALA was associated with the highest odds of achieving a good SER response compared to DIMS, with an odds ratio of 5.85. Notably, neither HAL monotherapy nor DIMSA showed a statistically significant improvement in the odds of a good SER response over DIMS. This suggests that the combination of HAL lenses with atropine may offer a distinct advantage in shifting children toward a more favorable refractive trajectory, even if the mean differences are modest.

The study also identified older age as an independent predictor of better treatment response. For both axial length and SER outcomes, older children were more likely to achieve a good response. This finding aligns with the natural history of myopia progression, which typically decreases with increasing age. The researchers noted that these associations should be interpreted with caution due to the non-randomized nature of the study. Significant baseline imbalances existed between the groups, with the DIMS group having a longer follow-up duration and a more myopic baseline refraction than the other groups. These factors may have contributed to the apparently poorer outcomes observed in the DIMS group.

The authors emphasized that their findings represent real-world associations rather than definitive causal effects. The retrospective design and potential for residual confounding mean that the observed differences in effectiveness may be influenced by unmeasured factors such as perceived progression risk or parental preference. Additionally, the one-year follow-up period is insufficient to assess long-term effectiveness, potential attenuation of treatment effects, or rebound effects. The researchers are continuing to follow this cohort and plan to report two- and three-year outcomes in future publications.

Despite these limitations, the study provides valuable preliminary evidence for the comparison of the four key myopia control strategies. The findings suggest that HAL spectacles are more effective as monotherapy compared to DIMS, and that HALA combination therapy may be the most potent strategy for children requiring maximal intervention. The distinct optical principles of HAL lenses, which may deliver a more potent and uniform defocus signal, could contribute to their superior performance in this population. The study highlights the importance of considering the specific optical design and the potential for synergistic effects when combining optical and pharmacological therapies.

Clinicians should weigh the potential for individual response against the additional burden and side effects of combination therapy when making treatment decisions. The decision to add atropine must be individualized, taking into account the child’s baseline risk factors, progression rate, and family history. Children with low progression risk may do well with HAL monotherapy, whereas those with high risk may benefit more from HALA as a first-line option. The study underscores the need for personalized approaches to myopia management, tailored to the specific needs and characteristics of each child.

Future prospective, randomized trials with balanced follow-up and baseline characteristics are needed to definitively establish the comparative efficacy of these interventions. Such studies should include cycloplegic refraction and longer follow-up periods to confirm the findings of this real-world study. Additionally, identifying predictive biomarkers or phenotypic characteristics that can distinguish optimal responders to monotherapy from those who may benefit more from combination therapy will be crucial for paving the way for a truly personalized approach to myopia management. The current study serves as a significant step in this direction, providing a comprehensive comparison of the available interventions in a large, real-world cohort.

Subject of Research: Comparison of myopia control interventions in Chinese children

Article Title: Comparison of effectiveness of four myopia control interventions in Chinese children: a real-world retrospective study

Article References: Chen, L., Sun, L., Chen, X., Liu, J., Li, J., Leung, H. Y., Zhang, J., & Lam, D. S. C. (2026). Comparison of effectiveness of four myopia control interventions in Chinese children: a real-world retrospective study. Eye and Vision, 13(1), Article 18. https://doi.org/10.1186/s40662-026-00487-z

Image Credits: AI Generated

DOI: 10.1186/s40662-026-00487-z

Keywords: myopia, spectacle lenses, HAL, DIMS, atropine, pediatric ophthalmology, axial length, refractive error, clinical trial, retrospective study, Comparison, effectiveness

News Source: Ophelia Keating. (November 7, 2026). HAL Lenses Outperform DIMS in Chinese Children’s Myopia Control. Scienmag.

Tags: atropineaxial lengthclinical trialcomparisonDIMSeffectivenessHALmyopiapediatric ophthalmologyrefractive errorRetrospective studyspectacle lenses
Share12Tweet7Share2ShareShareShare1

Related Posts

Pediatric Mononucleosis Study Finds Exploratory Links Between Viral Load and Laboratory Measures

Pediatric Mononucleosis Study Finds Exploratory Links Between Viral Load and Laboratory Measures

November 17, 2026
Unique Plasmid Found in Carbapenem-Resistant Klebsiella pneumoniae After Treatment Failure

Unique Plasmid Found in Carbapenem-Resistant Klebsiella pneumoniae After Treatment Failure

November 17, 2026

Machine Learning Models Predict Long-Term Surgical Mortality Across Emergency and Elective Patients

November 17, 2026

Collicular Microgliosis Maps to Synapse Loss and Varies by Sex

November 17, 2026

POPULAR NEWS

  • Sesbania Hay Replacement Modifies Lamb Muscle Lipids and Meat Flavor Precursors

    Sesbania Hay Replacement Modifies Lamb Muscle Lipids and Meat Flavor Precursors

    29 shares
    Share 12 Tweet 7
  • Human Guided Knowledge Fusion Enhances Industrial Fault Diagnosis Graphs and Retrieval

    29 shares
    Share 12 Tweet 7
  • Geostatistical Kriging Maps Regional Ionospheric Storm Anomalies Across Türkiye

    29 shares
    Share 12 Tweet 7
  • Pediatric Mononucleosis Study Finds Exploratory Links Between Viral Load and Laboratory Measures

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Open-Source FALCON Framework Automates Aerodynamic Airfoil Meshing and CFD Workflows

Sesbania Hay Replacement Modifies Lamb Muscle Lipids and Meat Flavor Precursors

Human Guided Knowledge Fusion Enhances Industrial Fault Diagnosis Graphs and Retrieval

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.